Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-14

Clinical Trial Update: Flax Lignans and Heart Health [NA]

View source ↗

Summary

Clinical trial evaluating flax lignans for hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flax lignans (secoisolariciresinol diglucoside (SDG))

Snippet

Sponsor: Iowa State University | Conditions: Hypercholesterolemia | NA | Status: COMPLETED